Vicebio

Vicebio Ltd is a biopharmaceutical company developing novel vaccines against life-threatening respiratory viral infections using its proprietary Molecular Clamp technology. This technology stabilizes viral glycoproteins, enabling the production of highly effective and easy-to-manufacture vaccines. The company is currently conducting a Phase I clinical trial for a bivalent vaccine targeting RSV and hMPV.

Buy Funded Startups lists

Funding Round: Series B

Funding Amount: $100M

Date: 23-Sep-2024

Investors: TCGX, Goldman Sachs Alternatives, Avoro Ventures, venBio, UniQuest, Medicxi

Markets: Biotechnology, Vaccines, Pharmaceuticals, Medical

HQ: London, England, United Kingdom

Founded: 2019

Website: https://www.vicebio.com

LinkedIn: https://www.linkedin.com/company/vicebio

Twitter:

Instagram: